Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2013-12

AUTHORS

Kathrin Dellas, Thomas Höhler, Thomas Reese, Florian Würschmidt, Erik Engel, Claus Rödel, Wolfgang Wagner, Michael Richter, Dirk Arnold, Jürgen Dunst

ABSTRACT

BACKGROUND: Preoperative radiochemotherapy (RCT) with 5-FU or capecitabine is the standard of care for patients with locally advanced rectal cancer (LARC). Preoperative RCT achieves pathological complete response rates (pCR) of 10-15%. We conducted a single arm phase II study to investigate the feasibility and efficacy of addition of bevacizumab and oxaliplatin to preoperative standard RCT with capecitabine. METHODS: Eligible patients had LARC (cT3-4; N0/1/2, M0/1) and were treated with preoperative RCT prior to planned surgery. Patients received conventionally fractionated radiotherapy (50.4 Gy in 1.8 Gy fractions) and simultaneous chemotherapy with capecitabine 825 mg/m2 bid (d1-14, d22-35) and oxaliplatin 50 mg/m2 (d1, d8, d22, d29). Bevacizumab 5 mg/kg was added on days 1, 15, and 29. The primary study objective was the pCR rate. RESULTS: 70 patients with LARC (cT3-4; N0/1, M0/1), ECOG < 2, were enrolled at 6 sites from 07/2008 through 02/2010 (median age 61 years [range 39-89], 68% male). At initial diagnosis, 84% of patients had clinical stage T3, 62% of patients had nodal involvement and 83% of patients were M0. Mean tumor distance from anal verge was 5.92 cm (± 3.68). 58 patients received the complete RCT (full dose RT and full dose of all chemotherapy). During preoperative treatment, grade 3 or 4 toxicities were experienced by 6 and 2 patients, respectively: grade 4 diarrhea and nausea in one patient (1.4%), respectively, grade 3 diarrhea in 2 patients (3%), grade 3 obstipation, anal abscess, anaphylactic reaction, leucopenia and neutropenia in one patient (1.4%), respectively. In total, 30 patients (46%) developed postoperative complications of any grade including one gastrointestinal perforation in one patient (2%), wound-healing problems in 7 patients (11%) and bleedings in 2 patients (3%). pCR was observed in 12/69 (17.4%) patients. Pathological downstaging (ypT < cT and ypN ≤ cN) was achieved in 31 of 69 patients (44.9%). All of the 66 operated patients had a R0 resection. 47 patients (68.1%) underwent sphincter preserving surgery. CONCLUSIONS: The addition of bevacizumab and oxaliplatin to RCT with capecitabine was well tolerated and did not increase perioperative morbidity or mortality. However, the pCR rate was not improved in comparison to other trials that used capecitabine or capecitabine/oxaliplatin in preoperative radiochemotherapy. More... »

PAGES

90

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1748-717x-8-90

DOI

http://dx.doi.org/10.1186/1748-717x-8-90

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1020342618

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/23587311


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal, Humanized", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bevacizumab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Capecitabine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemoradiotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Deoxycytidine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose Fractionation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorouracil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoadjuvant Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Organoplatinum Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rectal Neoplasms", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of L\u00fcbeck", 
          "id": "https://www.grid.ac/institutes/grid.4562.5", 
          "name": [
            "Department of Radiooncology, University of Kiel, Kiel, Germany", 
            "Department of Radiooncology, University of Luebeck, Luebeck, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dellas", 
        "givenName": "Kathrin", 
        "id": "sg:person.0777110562.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0777110562.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Prosper Hospital", 
          "id": "https://www.grid.ac/institutes/grid.459883.b", 
          "name": [
            "Prosper Hospital Recklinghausen, Recklinghausen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "H\u00f6hler", 
        "givenName": "Thomas", 
        "id": "sg:person.01046073601.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046073601.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Martin Luther University Halle-Wittenberg", 
          "id": "https://www.grid.ac/institutes/grid.9018.0", 
          "name": [
            "Department of Radiotherapy, Martin Luther University Halle-Wittenberg, Saale, Halle, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reese", 
        "givenName": "Thomas", 
        "id": "sg:person.01226265731.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226265731.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Private Practice of Radiooncology, Radiologische Allianz, Hamburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "W\u00fcrschmidt", 
        "givenName": "Florian", 
        "id": "sg:person.01301531013.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301531013.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Private Practice of Hematology and Medical Oncology, Hamburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Engel", 
        "givenName": "Erik", 
        "id": "sg:person.0704250625.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704250625.64"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Goethe University Frankfurt", 
          "id": "https://www.grid.ac/institutes/grid.7839.5", 
          "name": [
            "Department of Radiooncology, University of Frankfurt, Frankfurt, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "R\u00f6del", 
        "givenName": "Claus", 
        "id": "sg:person.01110566562.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110566562.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Radiooncology, Osnabrueck, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wagner", 
        "givenName": "Wolfgang", 
        "id": "sg:person.0723647650.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723647650.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Coordination Center for Clinical Trials, Saale, Halle, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Richter", 
        "givenName": "Michael", 
        "id": "sg:person.01044006441.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044006441.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Clinic for Medical Oncology, Tumor Biology Center Freiburg, Freiburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Arnold", 
        "givenName": "Dirk", 
        "id": "sg:person.01270303133.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270303133.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of L\u00fcbeck", 
          "id": "https://www.grid.ac/institutes/grid.4562.5", 
          "name": [
            "Department of Radiooncology, University of Luebeck, Luebeck, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dunst", 
        "givenName": "J\u00fcrgen", 
        "id": "sg:person.01013257674.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013257674.45"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1634/theoncologist.9-suppl_1-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000623077"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm988", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003700365", 
          "https://doi.org/10.1038/nm988"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm988", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003700365", 
          "https://doi.org/10.1038/nm988"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.23099", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005385290"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.25.8376", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006337920"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2004.11.017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006888724"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(10)70172-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007782854"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(12)70116-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009131199"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.33.1595", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010355293"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2011.05.016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010622517"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.2011.51", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016700441"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2007.07.2356", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017232703"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(12)70509-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017742674"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00066-010-2182-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018771318", 
          "https://doi.org/10.1007/s00066-010-2182-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa060829", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021609703"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.39.6036", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022439548"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2010.08.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025772498"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(12)70187-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026397736"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.40.1836", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027178418"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s003840050072", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028995544", 
          "https://doi.org/10.1007/s003840050072"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa040694", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031672074"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.sla.0000161980.46459.96", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031963250"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.sla.0000161980.46459.96", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031963250"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1748-717x-6-105", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033340022", 
          "https://doi.org/10.1186/1748-717x-6-105"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.17.5299", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033537766"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/02841860701697720", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033989128"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-010-1166-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034900487", 
          "https://doi.org/10.1245/s10434-010-1166-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-010-1166-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034900487", 
          "https://doi.org/10.1245/s10434-010-1166-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000421-200104000-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038222204"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000421-200104000-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038222204"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10350-004-6545-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038646562", 
          "https://doi.org/10.1007/s10350-004-6545-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1007/s10350-004-6545-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038646562"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.21.1771", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038668494"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.06.7629", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040853793"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.30.0855", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041540340"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.02.1329", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042089423"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2007.02.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042346131"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.34.4911", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043038502"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2009.02.037", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043461264"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.08.173", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044943271"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1111065", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045165077"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.33.5091", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045522021"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.08.3675", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048628945"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-010-0972-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049939887", 
          "https://doi.org/10.1245/s10434-010-0972-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-010-0972-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049939887", 
          "https://doi.org/10.1245/s10434-010-0972-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.2010-0030", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050446810"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00066-012-0073-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053415299", 
          "https://doi.org/10.1007/s00066-012-0073-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2002.10.088", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203153"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2003.02.505", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203419"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.29.15_suppl.3503", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083947619"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-12", 
    "datePublishedReg": "2013-12-01", 
    "description": "BACKGROUND: Preoperative radiochemotherapy (RCT) with 5-FU or capecitabine is the standard of care for patients with locally advanced rectal cancer (LARC). Preoperative RCT achieves pathological complete response rates (pCR) of 10-15%. We conducted a single arm phase II study to investigate the feasibility and efficacy of addition of bevacizumab and oxaliplatin to preoperative standard RCT with capecitabine.\nMETHODS: Eligible patients had LARC (cT3-4; N0/1/2, M0/1) and were treated with preoperative RCT prior to planned surgery. Patients received conventionally fractionated radiotherapy (50.4 Gy in 1.8 Gy fractions) and simultaneous chemotherapy with capecitabine 825 mg/m2 bid (d1-14, d22-35) and oxaliplatin 50 mg/m2 (d1, d8, d22, d29). Bevacizumab 5 mg/kg was added on days 1, 15, and 29. The primary study objective was the pCR rate.\nRESULTS: 70 patients with LARC (cT3-4; N0/1, M0/1), ECOG\u2009<\u20092, were enrolled at 6 sites from 07/2008 through 02/2010 (median age 61 years [range 39-89], 68% male). At initial diagnosis, 84% of patients had clinical stage T3, 62% of patients had nodal involvement and 83% of patients were M0. Mean tumor distance from anal verge was 5.92 cm (\u00b1 3.68). 58 patients received the complete RCT (full dose RT and full dose of all chemotherapy). During preoperative treatment, grade 3 or 4 toxicities were experienced by 6 and 2 patients, respectively: grade 4 diarrhea and nausea in one patient (1.4%), respectively, grade 3 diarrhea in 2 patients (3%), grade 3 obstipation, anal abscess, anaphylactic reaction, leucopenia and neutropenia in one patient (1.4%), respectively. In total, 30 patients (46%) developed postoperative complications of any grade including one gastrointestinal perforation in one patient (2%), wound-healing problems in 7 patients (11%) and bleedings in 2 patients (3%). pCR was observed in 12/69 (17.4%) patients. Pathological downstaging (ypT\u2009<\u2009cT and ypN\u2009\u2264\u2009cN) was achieved in 31 of 69 patients (44.9%). All of the 66 operated patients had a R0 resection. 47 patients (68.1%) underwent sphincter preserving surgery.\nCONCLUSIONS: The addition of bevacizumab and oxaliplatin to RCT with capecitabine was well tolerated and did not increase perioperative morbidity or mortality. However, the pCR rate was not improved in comparison to other trials that used capecitabine or capecitabine/oxaliplatin in preoperative radiochemotherapy.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/1748-717x-8-90", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1036451", 
        "issn": [
          "1748-717X"
        ], 
        "name": "Radiation Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "8"
      }
    ], 
    "name": "Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer", 
    "pagination": "90", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "60ed2ad31b1098245e2a8a7095d6b32b0e1e3f632eb6b949e4c30640bd3282c4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "23587311"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101265111"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1748-717x-8-90"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1020342618"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1748-717x-8-90", 
      "https://app.dimensions.ai/details/publication/pub.1020342618"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T18:25", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8675_00000536.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2F1748-717X-8-90"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1748-717x-8-90'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1748-717x-8-90'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1748-717x-8-90'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1748-717x-8-90'


 

This table displays all metadata directly associated to this object as RDF triples.

366 TRIPLES      21 PREDICATES      92 URIs      39 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1748-717x-8-90 schema:about N004fd57c289e41c0b50cb3a45efcac04
2 N0303827567b1407b82af4b577c57f85d
3 N0d0c10356705487e8bbc2ec026ec27cf
4 N3617badc4cea43c28ea2bc81ed7223ce
5 N3720f90f54284f5cbf3b10c64494f4ed
6 N488b0291064f48f5b145b11eea63e82f
7 N62e3124344ea403289870a7250f62ce9
8 N78c04c32558144438a37580c63c843b4
9 N7d62399be3d742a29fe59b30477e0d41
10 N7dc4d6e2acca4c2496d4b6490455236e
11 Na325e0a4129847208b3f63e9ff6c400d
12 Nbc91b9bc2bce4c45818f06a4929f0a6f
13 Nc597ef865ac14eb38308ee0f6e8b1d94
14 Nca5d8b1a9e394d9ab71fe0a4bf4111e8
15 Nd1ac3b8504614828873305bdb8199735
16 Ne1c4e2b8cc63420284b67d5fa9f85cf3
17 Nf095e58aa2c34cbda5b95610d0f60975
18 Nf7037693f8e8432397c9c250f3af7217
19 anzsrc-for:11
20 anzsrc-for:1103
21 schema:author N1b86b5d77d8d40e6b37d20c56a37bc71
22 schema:citation sg:pub.10.1007/s00066-010-2182-6
23 sg:pub.10.1007/s00066-012-0073-8
24 sg:pub.10.1007/s003840050072
25 sg:pub.10.1007/s10350-004-6545-x
26 sg:pub.10.1038/nm988
27 sg:pub.10.1186/1748-717x-6-105
28 sg:pub.10.1245/s10434-010-0972-9
29 sg:pub.10.1245/s10434-010-1166-1
30 https://doi.org/10.1001/jama.2011.51
31 https://doi.org/10.1002/cncr.23099
32 https://doi.org/10.1007/s10350-004-6545-x
33 https://doi.org/10.1016/j.ejca.2011.05.016
34 https://doi.org/10.1016/j.ijrobp.2004.11.017
35 https://doi.org/10.1016/j.ijrobp.2007.02.001
36 https://doi.org/10.1016/j.ijrobp.2007.07.2356
37 https://doi.org/10.1016/j.ijrobp.2009.02.037
38 https://doi.org/10.1016/j.ijrobp.2010.08.005
39 https://doi.org/10.1016/s1470-2045(10)70172-8
40 https://doi.org/10.1016/s1470-2045(12)70116-x
41 https://doi.org/10.1016/s1470-2045(12)70187-0
42 https://doi.org/10.1016/s1470-2045(12)70509-0
43 https://doi.org/10.1056/nejmoa040694
44 https://doi.org/10.1056/nejmoa060829
45 https://doi.org/10.1056/nejmoa1111065
46 https://doi.org/10.1080/02841860701697720
47 https://doi.org/10.1097/00000421-200104000-00001
48 https://doi.org/10.1097/01.sla.0000161980.46459.96
49 https://doi.org/10.1200/jco.2002.10.088
50 https://doi.org/10.1200/jco.2003.02.505
51 https://doi.org/10.1200/jco.2004.08.173
52 https://doi.org/10.1200/jco.2005.02.1329
53 https://doi.org/10.1200/jco.2006.06.7629
54 https://doi.org/10.1200/jco.2006.08.3675
55 https://doi.org/10.1200/jco.2008.17.5299
56 https://doi.org/10.1200/jco.2008.21.1771
57 https://doi.org/10.1200/jco.2009.25.8376
58 https://doi.org/10.1200/jco.2010.30.0855
59 https://doi.org/10.1200/jco.2010.33.1595
60 https://doi.org/10.1200/jco.2010.33.5091
61 https://doi.org/10.1200/jco.2010.34.4911
62 https://doi.org/10.1200/jco.2011.29.15_suppl.3503
63 https://doi.org/10.1200/jco.2011.39.6036
64 https://doi.org/10.1200/jco.2011.40.1836
65 https://doi.org/10.1634/theoncologist.2010-0030
66 https://doi.org/10.1634/theoncologist.9-suppl_1-2
67 schema:datePublished 2013-12
68 schema:datePublishedReg 2013-12-01
69 schema:description BACKGROUND: Preoperative radiochemotherapy (RCT) with 5-FU or capecitabine is the standard of care for patients with locally advanced rectal cancer (LARC). Preoperative RCT achieves pathological complete response rates (pCR) of 10-15%. We conducted a single arm phase II study to investigate the feasibility and efficacy of addition of bevacizumab and oxaliplatin to preoperative standard RCT with capecitabine. METHODS: Eligible patients had LARC (cT3-4; N0/1/2, M0/1) and were treated with preoperative RCT prior to planned surgery. Patients received conventionally fractionated radiotherapy (50.4 Gy in 1.8 Gy fractions) and simultaneous chemotherapy with capecitabine 825 mg/m2 bid (d1-14, d22-35) and oxaliplatin 50 mg/m2 (d1, d8, d22, d29). Bevacizumab 5 mg/kg was added on days 1, 15, and 29. The primary study objective was the pCR rate. RESULTS: 70 patients with LARC (cT3-4; N0/1, M0/1), ECOG < 2, were enrolled at 6 sites from 07/2008 through 02/2010 (median age 61 years [range 39-89], 68% male). At initial diagnosis, 84% of patients had clinical stage T3, 62% of patients had nodal involvement and 83% of patients were M0. Mean tumor distance from anal verge was 5.92 cm (± 3.68). 58 patients received the complete RCT (full dose RT and full dose of all chemotherapy). During preoperative treatment, grade 3 or 4 toxicities were experienced by 6 and 2 patients, respectively: grade 4 diarrhea and nausea in one patient (1.4%), respectively, grade 3 diarrhea in 2 patients (3%), grade 3 obstipation, anal abscess, anaphylactic reaction, leucopenia and neutropenia in one patient (1.4%), respectively. In total, 30 patients (46%) developed postoperative complications of any grade including one gastrointestinal perforation in one patient (2%), wound-healing problems in 7 patients (11%) and bleedings in 2 patients (3%). pCR was observed in 12/69 (17.4%) patients. Pathological downstaging (ypT < cT and ypN ≤ cN) was achieved in 31 of 69 patients (44.9%). All of the 66 operated patients had a R0 resection. 47 patients (68.1%) underwent sphincter preserving surgery. CONCLUSIONS: The addition of bevacizumab and oxaliplatin to RCT with capecitabine was well tolerated and did not increase perioperative morbidity or mortality. However, the pCR rate was not improved in comparison to other trials that used capecitabine or capecitabine/oxaliplatin in preoperative radiochemotherapy.
70 schema:genre research_article
71 schema:inLanguage en
72 schema:isAccessibleForFree true
73 schema:isPartOf N196dc862f0b84c24a99f9340fcc6ff55
74 Nd16b9c32252c4d1d8e225d49afa3987e
75 sg:journal.1036451
76 schema:name Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer
77 schema:pagination 90
78 schema:productId N0a7dbdf4ebec4ae28814a030dfadb622
79 N12553eb6b4fd4eb1a56e1034459d9390
80 N81db0b509edc45639a6ecd46c3d921ce
81 Nba0a5d04ce4d4ad196e233d25905f959
82 Ndf886870821e4db5ac465929566d1474
83 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020342618
84 https://doi.org/10.1186/1748-717x-8-90
85 schema:sdDatePublished 2019-04-10T18:25
86 schema:sdLicense https://scigraph.springernature.com/explorer/license/
87 schema:sdPublisher Na467bf82ab344c6998a9a5a2a2c16002
88 schema:url http://link.springer.com/10.1186%2F1748-717X-8-90
89 sgo:license sg:explorer/license/
90 sgo:sdDataset articles
91 rdf:type schema:ScholarlyArticle
92 N004fd57c289e41c0b50cb3a45efcac04 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Deoxycytidine
94 rdf:type schema:DefinedTerm
95 N0303827567b1407b82af4b577c57f85d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Bevacizumab
97 rdf:type schema:DefinedTerm
98 N087065e4e27740ccb6b5af248da897e6 rdf:first sg:person.01110566562.10
99 rdf:rest Ne8bf9e02be5b4943b79a41e18c37556b
100 N0a7dbdf4ebec4ae28814a030dfadb622 schema:name pubmed_id
101 schema:value 23587311
102 rdf:type schema:PropertyValue
103 N0d0c10356705487e8bbc2ec026ec27cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Antibodies, Monoclonal, Humanized
105 rdf:type schema:DefinedTerm
106 N12553eb6b4fd4eb1a56e1034459d9390 schema:name doi
107 schema:value 10.1186/1748-717x-8-90
108 rdf:type schema:PropertyValue
109 N196dc862f0b84c24a99f9340fcc6ff55 schema:issueNumber 1
110 rdf:type schema:PublicationIssue
111 N1b86b5d77d8d40e6b37d20c56a37bc71 rdf:first sg:person.0777110562.06
112 rdf:rest N5ff8137ae4b0421086439a2c808c2355
113 N3248e58f7b1c4bacada5270bd37f21a4 schema:name Coordination Center for Clinical Trials, Saale, Halle, Germany
114 rdf:type schema:Organization
115 N3617badc4cea43c28ea2bc81ed7223ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Humans
117 rdf:type schema:DefinedTerm
118 N3720f90f54284f5cbf3b10c64494f4ed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Male
120 rdf:type schema:DefinedTerm
121 N3efa10d2b99c41a39a8f6941909363bf rdf:first sg:person.01226265731.20
122 rdf:rest N9450f3dc70b445d3a434411f869a910e
123 N488b0291064f48f5b145b11eea63e82f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Capecitabine
125 rdf:type schema:DefinedTerm
126 N56474c46a32c42a79c9e1ade2207d2fd schema:name Department of Radiooncology, Osnabrueck, Germany
127 rdf:type schema:Organization
128 N57427464815c413d989e26a3ebc02293 schema:name Private Practice of Hematology and Medical Oncology, Hamburg, Germany
129 rdf:type schema:Organization
130 N5ff8137ae4b0421086439a2c808c2355 rdf:first sg:person.01046073601.62
131 rdf:rest N3efa10d2b99c41a39a8f6941909363bf
132 N62e3124344ea403289870a7250f62ce9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Aged
134 rdf:type schema:DefinedTerm
135 N78c04c32558144438a37580c63c843b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Dose Fractionation
137 rdf:type schema:DefinedTerm
138 N7d62399be3d742a29fe59b30477e0d41 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Neoadjuvant Therapy
140 rdf:type schema:DefinedTerm
141 N7d8f5a4b39fe48be9ad9d07b688eb18e rdf:first sg:person.01270303133.74
142 rdf:rest N88397e31fef84331a54af65cbc6fc2de
143 N7dc4d6e2acca4c2496d4b6490455236e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Adult
145 rdf:type schema:DefinedTerm
146 N81db0b509edc45639a6ecd46c3d921ce schema:name readcube_id
147 schema:value 60ed2ad31b1098245e2a8a7095d6b32b0e1e3f632eb6b949e4c30640bd3282c4
148 rdf:type schema:PropertyValue
149 N88397e31fef84331a54af65cbc6fc2de rdf:first sg:person.01013257674.45
150 rdf:rest rdf:nil
151 N9450f3dc70b445d3a434411f869a910e rdf:first sg:person.01301531013.52
152 rdf:rest Nd6abf6d7840842d6a6fc961efc2dd240
153 Na325e0a4129847208b3f63e9ff6c400d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Middle Aged
155 rdf:type schema:DefinedTerm
156 Na467bf82ab344c6998a9a5a2a2c16002 schema:name Springer Nature - SN SciGraph project
157 rdf:type schema:Organization
158 Nba0a5d04ce4d4ad196e233d25905f959 schema:name nlm_unique_id
159 schema:value 101265111
160 rdf:type schema:PropertyValue
161 Nbc91b9bc2bce4c45818f06a4929f0a6f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Organoplatinum Compounds
163 rdf:type schema:DefinedTerm
164 Nc597ef865ac14eb38308ee0f6e8b1d94 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Aged, 80 and over
166 rdf:type schema:DefinedTerm
167 Nca5d8b1a9e394d9ab71fe0a4bf4111e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Rectal Neoplasms
169 rdf:type schema:DefinedTerm
170 Nd16b9c32252c4d1d8e225d49afa3987e schema:volumeNumber 8
171 rdf:type schema:PublicationVolume
172 Nd1ac3b8504614828873305bdb8199735 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Antineoplastic Combined Chemotherapy Protocols
174 rdf:type schema:DefinedTerm
175 Nd3c33d28d6934378b865e7313e854304 schema:name Clinic for Medical Oncology, Tumor Biology Center Freiburg, Freiburg, Germany
176 rdf:type schema:Organization
177 Nd6abf6d7840842d6a6fc961efc2dd240 rdf:first sg:person.0704250625.64
178 rdf:rest N087065e4e27740ccb6b5af248da897e6
179 Nd6e07202050246f2bc44b4f8f17db6fc schema:name Private Practice of Radiooncology, Radiologische Allianz, Hamburg, Germany
180 rdf:type schema:Organization
181 Ndf886870821e4db5ac465929566d1474 schema:name dimensions_id
182 schema:value pub.1020342618
183 rdf:type schema:PropertyValue
184 Ne1c4e2b8cc63420284b67d5fa9f85cf3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Fluorouracil
186 rdf:type schema:DefinedTerm
187 Ne5ec43c707824764ada00e7115ea4821 rdf:first sg:person.01044006441.91
188 rdf:rest N7d8f5a4b39fe48be9ad9d07b688eb18e
189 Ne8bf9e02be5b4943b79a41e18c37556b rdf:first sg:person.0723647650.14
190 rdf:rest Ne5ec43c707824764ada00e7115ea4821
191 Nf095e58aa2c34cbda5b95610d0f60975 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Chemoradiotherapy
193 rdf:type schema:DefinedTerm
194 Nf7037693f8e8432397c9c250f3af7217 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Female
196 rdf:type schema:DefinedTerm
197 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
198 schema:name Medical and Health Sciences
199 rdf:type schema:DefinedTerm
200 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
201 schema:name Clinical Sciences
202 rdf:type schema:DefinedTerm
203 sg:journal.1036451 schema:issn 1748-717X
204 schema:name Radiation Oncology
205 rdf:type schema:Periodical
206 sg:person.01013257674.45 schema:affiliation https://www.grid.ac/institutes/grid.4562.5
207 schema:familyName Dunst
208 schema:givenName Jürgen
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013257674.45
210 rdf:type schema:Person
211 sg:person.01044006441.91 schema:affiliation N3248e58f7b1c4bacada5270bd37f21a4
212 schema:familyName Richter
213 schema:givenName Michael
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044006441.91
215 rdf:type schema:Person
216 sg:person.01046073601.62 schema:affiliation https://www.grid.ac/institutes/grid.459883.b
217 schema:familyName Höhler
218 schema:givenName Thomas
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046073601.62
220 rdf:type schema:Person
221 sg:person.01110566562.10 schema:affiliation https://www.grid.ac/institutes/grid.7839.5
222 schema:familyName Rödel
223 schema:givenName Claus
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110566562.10
225 rdf:type schema:Person
226 sg:person.01226265731.20 schema:affiliation https://www.grid.ac/institutes/grid.9018.0
227 schema:familyName Reese
228 schema:givenName Thomas
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226265731.20
230 rdf:type schema:Person
231 sg:person.01270303133.74 schema:affiliation Nd3c33d28d6934378b865e7313e854304
232 schema:familyName Arnold
233 schema:givenName Dirk
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270303133.74
235 rdf:type schema:Person
236 sg:person.01301531013.52 schema:affiliation Nd6e07202050246f2bc44b4f8f17db6fc
237 schema:familyName Würschmidt
238 schema:givenName Florian
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301531013.52
240 rdf:type schema:Person
241 sg:person.0704250625.64 schema:affiliation N57427464815c413d989e26a3ebc02293
242 schema:familyName Engel
243 schema:givenName Erik
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704250625.64
245 rdf:type schema:Person
246 sg:person.0723647650.14 schema:affiliation N56474c46a32c42a79c9e1ade2207d2fd
247 schema:familyName Wagner
248 schema:givenName Wolfgang
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723647650.14
250 rdf:type schema:Person
251 sg:person.0777110562.06 schema:affiliation https://www.grid.ac/institutes/grid.4562.5
252 schema:familyName Dellas
253 schema:givenName Kathrin
254 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0777110562.06
255 rdf:type schema:Person
256 sg:pub.10.1007/s00066-010-2182-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018771318
257 https://doi.org/10.1007/s00066-010-2182-6
258 rdf:type schema:CreativeWork
259 sg:pub.10.1007/s00066-012-0073-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053415299
260 https://doi.org/10.1007/s00066-012-0073-8
261 rdf:type schema:CreativeWork
262 sg:pub.10.1007/s003840050072 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028995544
263 https://doi.org/10.1007/s003840050072
264 rdf:type schema:CreativeWork
265 sg:pub.10.1007/s10350-004-6545-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1038646562
266 https://doi.org/10.1007/s10350-004-6545-x
267 rdf:type schema:CreativeWork
268 sg:pub.10.1038/nm988 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003700365
269 https://doi.org/10.1038/nm988
270 rdf:type schema:CreativeWork
271 sg:pub.10.1186/1748-717x-6-105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033340022
272 https://doi.org/10.1186/1748-717x-6-105
273 rdf:type schema:CreativeWork
274 sg:pub.10.1245/s10434-010-0972-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049939887
275 https://doi.org/10.1245/s10434-010-0972-9
276 rdf:type schema:CreativeWork
277 sg:pub.10.1245/s10434-010-1166-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034900487
278 https://doi.org/10.1245/s10434-010-1166-1
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1001/jama.2011.51 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016700441
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1002/cncr.23099 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005385290
283 rdf:type schema:CreativeWork
284 https://doi.org/10.1007/s10350-004-6545-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1038646562
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1016/j.ejca.2011.05.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010622517
287 rdf:type schema:CreativeWork
288 https://doi.org/10.1016/j.ijrobp.2004.11.017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006888724
289 rdf:type schema:CreativeWork
290 https://doi.org/10.1016/j.ijrobp.2007.02.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042346131
291 rdf:type schema:CreativeWork
292 https://doi.org/10.1016/j.ijrobp.2007.07.2356 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017232703
293 rdf:type schema:CreativeWork
294 https://doi.org/10.1016/j.ijrobp.2009.02.037 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043461264
295 rdf:type schema:CreativeWork
296 https://doi.org/10.1016/j.ijrobp.2010.08.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025772498
297 rdf:type schema:CreativeWork
298 https://doi.org/10.1016/s1470-2045(10)70172-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007782854
299 rdf:type schema:CreativeWork
300 https://doi.org/10.1016/s1470-2045(12)70116-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1009131199
301 rdf:type schema:CreativeWork
302 https://doi.org/10.1016/s1470-2045(12)70187-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026397736
303 rdf:type schema:CreativeWork
304 https://doi.org/10.1016/s1470-2045(12)70509-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017742674
305 rdf:type schema:CreativeWork
306 https://doi.org/10.1056/nejmoa040694 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031672074
307 rdf:type schema:CreativeWork
308 https://doi.org/10.1056/nejmoa060829 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021609703
309 rdf:type schema:CreativeWork
310 https://doi.org/10.1056/nejmoa1111065 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045165077
311 rdf:type schema:CreativeWork
312 https://doi.org/10.1080/02841860701697720 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033989128
313 rdf:type schema:CreativeWork
314 https://doi.org/10.1097/00000421-200104000-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038222204
315 rdf:type schema:CreativeWork
316 https://doi.org/10.1097/01.sla.0000161980.46459.96 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031963250
317 rdf:type schema:CreativeWork
318 https://doi.org/10.1200/jco.2002.10.088 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203153
319 rdf:type schema:CreativeWork
320 https://doi.org/10.1200/jco.2003.02.505 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203419
321 rdf:type schema:CreativeWork
322 https://doi.org/10.1200/jco.2004.08.173 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044943271
323 rdf:type schema:CreativeWork
324 https://doi.org/10.1200/jco.2005.02.1329 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042089423
325 rdf:type schema:CreativeWork
326 https://doi.org/10.1200/jco.2006.06.7629 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040853793
327 rdf:type schema:CreativeWork
328 https://doi.org/10.1200/jco.2006.08.3675 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048628945
329 rdf:type schema:CreativeWork
330 https://doi.org/10.1200/jco.2008.17.5299 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033537766
331 rdf:type schema:CreativeWork
332 https://doi.org/10.1200/jco.2008.21.1771 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038668494
333 rdf:type schema:CreativeWork
334 https://doi.org/10.1200/jco.2009.25.8376 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006337920
335 rdf:type schema:CreativeWork
336 https://doi.org/10.1200/jco.2010.30.0855 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041540340
337 rdf:type schema:CreativeWork
338 https://doi.org/10.1200/jco.2010.33.1595 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010355293
339 rdf:type schema:CreativeWork
340 https://doi.org/10.1200/jco.2010.33.5091 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045522021
341 rdf:type schema:CreativeWork
342 https://doi.org/10.1200/jco.2010.34.4911 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043038502
343 rdf:type schema:CreativeWork
344 https://doi.org/10.1200/jco.2011.29.15_suppl.3503 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083947619
345 rdf:type schema:CreativeWork
346 https://doi.org/10.1200/jco.2011.39.6036 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022439548
347 rdf:type schema:CreativeWork
348 https://doi.org/10.1200/jco.2011.40.1836 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027178418
349 rdf:type schema:CreativeWork
350 https://doi.org/10.1634/theoncologist.2010-0030 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050446810
351 rdf:type schema:CreativeWork
352 https://doi.org/10.1634/theoncologist.9-suppl_1-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000623077
353 rdf:type schema:CreativeWork
354 https://www.grid.ac/institutes/grid.4562.5 schema:alternateName University of Lübeck
355 schema:name Department of Radiooncology, University of Kiel, Kiel, Germany
356 Department of Radiooncology, University of Luebeck, Luebeck, Germany
357 rdf:type schema:Organization
358 https://www.grid.ac/institutes/grid.459883.b schema:alternateName Prosper Hospital
359 schema:name Prosper Hospital Recklinghausen, Recklinghausen, Germany
360 rdf:type schema:Organization
361 https://www.grid.ac/institutes/grid.7839.5 schema:alternateName Goethe University Frankfurt
362 schema:name Department of Radiooncology, University of Frankfurt, Frankfurt, Germany
363 rdf:type schema:Organization
364 https://www.grid.ac/institutes/grid.9018.0 schema:alternateName Martin Luther University Halle-Wittenberg
365 schema:name Department of Radiotherapy, Martin Luther University Halle-Wittenberg, Saale, Halle, Germany
366 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...